Conflict of interest
The admission CTG: is there any evidence for still using the test?
Article first published online: 9 MAR 2013
© 2013 The Authors Acta Obstetricia et Gynecologica Scandinavica © 2013 Nordic Federation of Societies of Obstetrics and Gynecology
Acta Obstetricia et Gynecologica Scandinavica
Volume 92, Issue 6, pages 613–619, June 2013
How to Cite
The admission CTG: is there any evidence for still using the test? Acta Obstet Gynecol Scand 2013 DOI: 10.1111/aogs.12091..
The author has stated explicitly that there are no conflicts of interest in connection with this article.
- Issue published online: 16 MAY 2013
- Article first published online: 9 MAR 2013
- Accepted manuscript online: 30 JAN 2013 06:17AM EST
- Manuscript Accepted: 8 JAN 2013
- Manuscript Received: 1 AUG 2012
- Admission CTG;
- intrapartum care;
- screening test;
- fetal distress
Admission cardiotocography (CTG) was introduced as a screening test for fetal distress in labor in the late 1980s. No systematic assessments of the test were performed before it was taken into widespread use. A screening test is meant to identify individuals with an increased risk for a disease or condition before symptoms occur, to prevent and reduce morbidity or mortality. A screening test should be evaluated according to its effectiveness, prognostic values and reliability. A careful review of the research literature states that routine use of the admission CTG in low-risk women increases the incidence of minor obstetric interventions, may increase the incidence of cesarean sections, but has no impact on other important outcomes. The prognostic values are poor, and the reliability varies from good to poor. There is no evidence showing that the admission CTG is beneficial, and the test should not be offered to low-risk women.